Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 25173583

Phase II study of oral ridaforolimus in women with recurrent or metastatic endometrial cancer.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Gynecol Oncol
Publication date
2014 Nov
First author
Tsoref D

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Tsoref D
      type
      Author
    2. name
      Welch S
      type
      Author
    3. name
      Lau S
      type
      Author
    4. name
      Biagi J
      type
      Author
    5. name
      Tonkin K
      type
      Author
    6. name
      Martin LA
      type
      Author
    7. name
      Ellard S
      type
      Author
    8. name
      Ghatage P
      type
      Author
    9. name
      Elit L
      type
      Author
    10. name
      Mackay HJ
      type
      Author
    11. name
      Allo G
      type
      Author
    12. name
      Tsao MS
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Tsoref D
      type
      Author
    2. name
      Welch S
      type
      Author
    3. name
      Lau S
      type
      Author
    4. name
      Biagi J
      type
      Author
    5. name
      Tonkin K
      type
      Author
    6. name
      Martin LA
      type
      Author
    7. name
      Ellard S
      type
      Author
    8. name
      Ghatage P
      type
      Author
    9. name
      Elit L
      type
      Author
    10. name
      Mackay HJ
      type
      Author
    11. name
      Allo G
      type
      Author
    12. name
      Tsao MS
      type
      Author
    bibliography ids
    1. nci-bib-104878fdc41e80ef753d876b
    book metadata
    content sha256
    0431b26a88396517e2a06de6b46b00622efa2a3d473d0573c8669435913886ff
    document type
    citation
    dois
    1. 10.1016/j.ygyno.2014.06.033
    electronic publication date
    display
    2014 Aug 28
    precision
    day
    year
    2014
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:25173583
    immutable id
    pubmed:25173583@0431b26a88396517e2a06de6b46b00622efa2a3d473d0573c8669435913886ff
    journal
    abbreviation
    Gynecol Oncol
    issn electronic
    1095-6859
    issn print
    0090-8258
    issue
    2
    name
    Gynecologic oncology
    nlm unique id
    0365304
    pages
    184-9
    volume
    135
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      25173583
      provenance
      batch id
      69903be8ceab8801c81a
      provider
      NCBI PubMed ESummary
      record sha256
      fb008f4849e50d734968ee6832ecd7e28aac827087dc432ec4ed69a2f0104e7a
      response sha256
      1e367491c3c459a93f45b3db99ca1f9293ed2287c48bdf758bb088ffcd7c96eb
      retrieved at
      2026-09-09T23:47:05.208886+00:00
      publication date
      display
      2014 Nov
      precision
      month
      year
      2014
      publication types
      1. Clinical Trial, Phase II
      2. Journal Article
      3. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/25173583/
      title
      Phase II study of oral ridaforolimus in women with recurrent or metastatic endometrial cancer.

      Preserved source evidence · Not medical advice